Potentially inappropriate medications in older adults living with HIV
- 9 June 2020
- journal article
- research article
- Published by Wiley in HIV Medicine
- Vol. 21 (8) , 541-546
Abstract
Objectives: We assessed the prevalence of potentially inappropriate medication (PIM) among older (≥ 65 years) people living with HIV (O‐PLWH) in the region of Madrid.Methods: We analysed the dispensation registry of community and hospital pharmacies from the Madrid Regional Health Service (SERMAS) for the period between 1 January and 30 June 2017, looking specifically at PIMs according to the 2019 Beers criteria. Co‐medications were classified according to the Anatomical Therapeutic Chemical (ATC) classification system.Results: A total of 6 636 451 individuals received medications. Of these individuals, 22 945 received antiretrovirals (ARVs), and of these 1292 were O‐PLWH. Overall, 1135 (87.8%) O‐PLWH were taking at least one co‐medication, and polypharmacy (at least five co‐medications) was observed in 852 individuals (65.9%). A PIM was identified in 482 (37.3%) O‐PLWH. Factors independently associated with PIM were polypharmacy [adjusted odds ratio (aOR) 7.08; 95% confidence interval (CI) 5.16–9.72] and female sex (aOR 1.75; 95% CI 1.30–2.35). The distribution of PIMs according to ATC drug class were nervous system drugs (n = 369; 28.6%), musculoskeletal system drugs (n = 140; 10.8%), gastrointestinal and metabolism drugs (n = 72; 5.6%), cardiovascular drugs (n = 61; 4.7%), respiratory system drugs (n = 13; 1.0%), antineoplastic and immunomodulating drugs (n = 10; 0.8%), and systemic anti‐infectives (n = 2; 0.2%). Five drugs accounted for 84.8% of the 482O PLWH with PIMs: lorazepam (38.2%), ibuprofen (18.0%), diazepam (10.2%), metoclopramide (9.9%), and zolpidem (8.5%).Conclusions: Prescription of PIMs is highly prevalent in O‐PLWH. Consistent with data in uninfected elderly people, the most frequently observed PIMs were benzodiazepines and nonsteroidal anti‐inflammatory drugs . Targeted interventions are warranted to reduce inappropriate prescribing and polypharmacy in this vulnerable population.Keywords
Funding Information
- Instituto de Salud Carlos III (RD16/0025/0017)
This publication has 20 references indexed in Scilit:
- Polypharmacy and Drug–Drug Interactions in People Living With Human Immunodeficiency Virus in the Region of Madrid, Spain: A Population-Based StudyClinical Infectious Diseases, 2019
- American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older AdultsJournal of the American Geriatrics Society, 2019
- Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteriaEuropean Journal of Clinical Pharmacology, 2018
- The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countriesEuropean Journal of Clinical Pharmacology, 2015
- Potentially Inappropriate Medication Use in Older Patients in Swiss Managed Care Plans: Prevalence, Determinants and Association with HospitalizationPLOS ONE, 2014
- Inappropriate Prescribing and Related Hospital Admissions in Frail Older Persons According to the STOPP and START CriteriaDrugs & Aging, 2012
- Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General PopulationClinical Infectious Diseases, 2011
- Potentially Inappropriate Medications Defined by STOPP Criteria and the Risk of Adverse Drug Events in Older Hospitalized PatientsArchives of internal medicine (1960), 2011
- HIV and Aging: Time for a New ParadigmCurrent HIV/AIDS Reports, 2010
- STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validationInt. Journal of Clinical Pharmacology and Therapeutics, 2008